AXIM BIOTECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 0.00 shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 500.00K shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 300.00K shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | |
| 2022-03-31 | 500.00K shares 10-Q · filed 2022-05-23 | |
| 2021-12-31 | 300.00K shares 10-K · filed 2023-04-17 | |
| 2020-12-31 | 0.00 shares 10-K/A · filed 2021-04-26 | |
| 2019-12-31 | 0.00 shares 10-K/A · filed 2021-04-26 |